January 16, 2025
Now in its 8th year, UC San Diego’s Accelerating Innovation to Market (AIM) program kicks off what promises to be yet another successful year with the announcement of its latest roster of awarded projects for 2025. This dynamic initiative, led by the Office of Innovation and Commercialization, focuses on expediting…
September 6, 2022
Noted businessman and philanthropist T. Denny Sanford has committed $150 million in new funding to expand and, in some ways, quite literally launch stem cell research and regenerative medicine at University of California San Diego into new spaces and endeavors.
January 24, 2022
A joint gift to the University of Southern California (USC) and the University of California San Diego totaling $50 million from the Epstein Family Foundation will drive Alzheimer’s research and accelerate the search for treatments and a cure.
November 1, 2024
Throughout the day-long event, participants exchanged views on current issues in health and medicine, from addiction to hospital cybersecurity.
January 7, 2016
…Companies of Johnson & Johnson, to identify new therapeutic targets for Chagas disease, a parasitic infection that is the leading cause of heart failure in Latin America.
November 10, 2022
An international symposium November 17-18, 2022 at UC San Diego will discuss current clinical trials using gene therapy, here and abroad.
August 6, 2024
…physicians diagnose patients faster and more accurately; predict which drugs will be most successful for specific patients; and even aid in the process of developing new therapeutic treatments for retinal diseases.
October 10, 2023
They flew through Category 2 hurricanes, helped develop antibody therapeutics for cancer patients, gained firsthand experience in the pharmaceutical industry and more. These five students are back on campus after gaining real-world exposure to their chosen career paths this summer.
